1. 1871 Inhibition of mTOR in combination with chemotherapy and angiogenic blockade shows activity in metaplastic breast cancer, an aggressive, chemo-refractory subtype of triple-negative breast cancer (TNBC). (September 2015) Authors: Basho, R.; Janku, F.; Helgason, T.; Gilcrease, M.; Booser, D.; Karp, D.; Meric-Bernstam, F.; Wheler, J.; Valero, V.; Albarracin, C.; Litton, J.; Chavez-MacGregor, M.; Ibrahim, N.; Murray, J.; Koenig, K.; Hong, D.; Subbiah, V.; Kurzrock, R.; Moulder, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗